Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
0Customers
2Debt Items
0Related Chains
Source-Backed Evidence Depth
DiaMedica Therapeutics Inc. (DMAC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
4Total relationships
2Distinct source URLs
4High confidence
0.905Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
DiaMedica Therapeutics Inc. Suppliers
Ticker
Name
Confidence
Evidence
CATALENT-PHARMA-SOLUTIONS-LLC
CATALENT-PHARMA-SOLUTIONS-LLC
92%
We rely on Catalent Pharma Solutions, LLC (Catalent), a contract development and manufacturing organization (CDMO) with proven GMP experience in the manufacturing of recombinant proteins for clinical…
DiaMedica Therapeutics Inc. Customers
No clients on recordDiaMedica Therapeutics Inc. does not appear to disclose named customer relationships in its verified regulatory filings. Many companies do not publicly name customers in regulatory disclosures.
DiaMedica Therapeutics Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
DMAC-DEBT
Debt stack $212,000
90%
Market cache reports total debt of $212,000.
DMAC-DEBT-9090
Warrants outstanding: 607000
90%
xbrl warrant detail from xbrl 2018-12-31.
DiaMedica Therapeutics Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for DiaMedica Therapeutics Inc..
DiaMedica Therapeutics Inc. Ownership
Holder
Name
Confidence
Evidence
DMAC-OWNER-COOPERMAN-LEON-G
COOPERMAN LEON G
90%
13F overlay lists COOPERMAN LEON G as top holder; 98 tracked holders.
DiaMedica Therapeutics Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
